Aberrant expression of microRNAs (miRNAs) has been involved in the development and progression of malignancy. MicroRNA-9 (miR-9) has been confirmed to be underexpressed in many types of cancers. However, the relationship between miR-9 and the Wnt/bcatenin signaling pathway in oral squamous cell carcinoma (OSCC) remains largely unknown. Here we showed that the miR-9 was underexpressed in patients with OSCC and several OSCC cell lines. Lentivirus-mediated miR-9 overexpression in highly aggressive (Tca8113 and SCC-9) tumor cells significantly inhibited proliferation of the two cell lines in vitro and in vivo. Furthermore, we found that the CXC chemokine receptor 4 (CXCR4) gene was a direct target of miR-9. RNA interference silencing of CXCR4 proved that miR-9 underexpression led to constitutive activation of b-catenin through activation of CXCR4 expression in OSCC cells. Finally, we also analyzed the possible relationship between miR-9 and the genes downstream of the Wnt/b-catenin pathway in OSCC development and progression. These results provide new evidence of miR-9 as a promising tumor gene therapeutic target for OSCC patients.
INTRODUCTION
Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors in southeast Asia, affecting approximately 300 000 patients worldwide each year. 1, 2 It is identified as a significant public health threat worldwide because its treatment often produces dysfunction and distortions in speech, mastication and swallowing, dental health and even in the ability to interact socially. 3 Despite improvements in these therapies, the 5-year survival rate has not improved significantly and remains at about 50%. 4 Previous studies have suggested that the formation of OSCC is related to the rates of cell proliferation and apoptosis. 5, 6 Therefore, understanding the main regulatory mechanism of this malignancy is the key to develop novel and effective therapeutic strategies for OSCC.
The discovery of non-coding RNA in the human genome was an important conceptual breakthrough in the post-genome sequencing era. MicroRNAs (miRNAs) are short, highly conserved small non-coding RNA molecules of about 20-22 nucleotides in length that regulate gene expression by binding to the 3 0 untranslated region (3 0 -UTR) of the complementary mRNA sequence, resulting in translational repression and gene silencing. 7, 8 An increasing body of evidence has suggested that the aberrant expression of miRNAs may lead to the development and progression of malignancy, 9, 10 including OSCC. MiR-21 is overexpressed and displays oncogenic activity in various carcinomas. 11 By multivariate analyses, miR-21 expression is indicated as an independent predictor of poor survival for patients with OSCC. 12 Another study supports a strong association of high levels of miR-21 and significantly decreased five-year survival in patients with HNSCC. 13 In addition, miR-100, -125b, -133a, -133b, -137 and193a are frequently downregulated in OSCC. 14 Reduced levels of miR-138 and -222 have been proved to be related to high metastatic potential of OSCC. 15 MicroRNA-9 (miR-9), initially demonstrated to function in neurogenesis, has been confirmed to be underexpressed in many types of cancers, including nasopharyngeal carcinoma, 16 colon cancer, 17 breast cancer, 18 and melanoma, 19 all of which is indicative of a tumor suppressor potential, whereas miR-9 is overexpressed in hepatocellular carcinoma, 20 brain cancer 21 and Hodgkin's lymphoma, 22 suggesting oncomir activity for miR-9 in these cancers.
Chemokines, a superfamily of small cytokine-like proteins, can bind to and activate a family of seven transmembrane G-proteincoupled receptors, the chemokine receptors. CXC chemokine receptor 4 (CXCR4) is expressed on multiple cell types including lymphocytes, hematopoietic stem cells, endothelial and epithelial cells, and cancer cells. 23 In fact, CXCR4 and its ligand stromal cellderived factor-1, also known as CXCL12, have been involved in tumor progression, angiogenesis, metastasis and survival. 24 In addition, Wnt/b-catenin signal transduction is a pathway that results in the cytoplasmic protein b-catenin entering the nucleus to modulate transcription. When the pathway is not activated, bcatenin is subject to a 'futile cycle' of continual synthesis and destruction by the b-catenin destruction complex, comprised of the scaffold proteins Axin and APC and the kinases GSK3 and casein kinase-1. 25 Based on previous research on the role of miR-9, CXCR4 and the Wnt pathway, we hypothesized that miR-9 regulates CXCR4 expression in OSCC progression through the Wnt/b-catenin pathway. To explore the roles of miR-9 in OSCC, in the present study, we first investigated the expression level of miR-9 in OSCC cells, and tested its effects on cell growth, apoptosis and colony formation in vitro and tumorigenesis in vivo. Second, we identified that the CXCR4 gene was a target of miR-9 in OSCC. Finally, we also analyzed the possible relationship between miR-9 and the downstream genes of the Wnt/b-catenin pathway in OSCC formation and progression. Our study may provide a better understanding of OSCC tumorigenesis. This study may provide new evidence for miR-9 as a promising gene therapeutic target for OSCC.
RESULTS
Expression levels of miR-9 in OSCC clinical specimens and cell lines The four oral squamous cell carcinoma cell lines (Tca8113, SCC-4, SCC-9 and SCC-25) were compared with human normal oral keratinocytes. The miR-9 expression in Tca8113, SCC-4, SCC-9 and SCC-25 cells was clearly downregulated by 2-10-fold (Figure 1a) . The Tca8113 and SCC-9 OSCC cell lines, which possess the lowest levels of miR-9 expression among all tested OSCC cell lines, were selected for further studies. In addition, we analyzed the expression levels of miR-9 in 16 clinical tongue oral squamous cell carcinoma specimens and their adjacent non-cancerous specimens. The results indicate that the expression levels of miR-9 were significantly lower in the 16 clinical tongue OSCC specimens than those in the corresponding adjacent non-cancerous specimens (P ¼ 0.0035) (Figure 1b ). In addition, to identify the role of the expression levels of miR-9 transcript and CXCR4 protein on OSCC malignant progression, we performed immunohistochemistry (IHC) for CXCR4 protein expression and real-time RT-PCR for miR-9 expression in metastasis (specimens from patients with neck lymph nodes metastasis) and non-metastasis (specimens from patients without neck lymph nodes metastasis) OSCC cells. Supplementary Figure 1 demonstrated that the miR-9 level was significantly decreased in metastasis OSCC specimens, compared with that in non-metastasis OSCC specimens (P ¼ 0.0059); however, the CXCR4 level was significantly increased in metastasis OSCC specimens, compared to that in nonmetastasis OSCC specimens.
Effects of miR-9 overexpression through lentivirus vector on the proliferation and invasion of Tca8113 and SCC-9 cells in vitro Firstly, we expressed miR-9 recombinant lentivirus vector in the highly malignant Tca8113 and SCC-9 cell lines (Figure 1c ). To determine whether the recombinant vectors were transduced into tumor cells, green fluorescent protein (GFP) expression of Tca8113 and SCC-9 cells in mock, miR-control and miR-9 LV groups was assessed using fluorescence microscope and flow cytometry. The results indicate that the delivery efficiency of miRcontrol and miR-9 LV was more than 95%, and no GFP expression was observed in Tca8113 and SCC-9 mock groups, as expected. After miR-control (MOI ¼ 50) and miR-9 LV (MOI ¼ 50) transduction for 72 h in Tca8113 and SCC-9 cells, the expression levels of miR-9 were substantially increased 8-9-fold in miR-9 LV expressing Tca8113 and SCC-9 cells, respectively, compared to their parental cells (Figures 1d-g ). To investigate whether miR-9 overexpression affects Tca8113 and SCC-9 cells invasion, we conducted three-dimensional cell migration assays using transwell chambers and invasion assays with matrigel-coated millicell chambers. The results indicate that miR-9 overexpression decreased cell invasion by B80% compared with controls (Supplementary Figure 2) .
The XTT assay demonstrated that cell proliferation was significantly inhibited in miR-9 transfectants in comparison with the mock or miR-control transfectant cells. Specifically, we observed the following growth, expressed as a percentage of the control: (1) Tca8113-mock, 100.0 ± 8.4; miR-control, 91 ± 3.2; miR-9, 20.2 ± 4.2; and (2) SCC-9 mock, 100.0 ± 11.2; miR-control, 104.3±13.6; miR-9, 34.8±3.5; with Po0.01 for both (Figures 2a  and b ). Following this, we also used the plate colony formation assays to assess the effect of miR-9 expression on proliferation of OSCC cell lines in vitro. Elevated miR-9 expression significantly decreased the Tca8113 and SCC-9 cells colony formation (Po0.01) (Figures 2c-e) .
The miR-9 overexpression promotes cell cycle arrest and apoptosis of OSCC cells in vitro To detect the effects of miR-9 expression on OSCC cell proliferation and apoptosis, we firstly examined the cell cycle distribution of cells treated with miR-9 in the Tca8113 and SCC-9 cell lines. After transduction with miR-9 (MOI ¼ 50) and miR-control (MOI ¼ 50) for 72 h in Tca8113 and SCC-9 cells, both of the cell lines showed decreased accumulation in S and G 2 /M phases and increased accumulation in G 1 and Sub-G 1 phase. After 72 h of transduction with miR-9, the percentage of cells in the S phase decreased from B29 to 19% in Tca8113 and from 36 to 20% in SCC-9 cells. The percentage of cells in the G 2 /M phase decreased from B19 to 10% in Tca8113 and from 18 to 11% in SCC-9 cells. Conversely, the percentage of cells in Sub-G 1 phase increased from B4 to 18% in Tca8113 and from 2% to 21% in SCC-9 cells. Interestingly, the percentage of cells in G 1 phase increased from B49 to 53% in Tca8113 and from 44 to 48% in SCC-9 cells (Figures 3a-c) . The results suggested that CXCR4 downregulation might promote OSCC cells apoptosis.
Following this, we used an Annexin V-FITC kit to determine the percentage of cells that underwent apoptosis. After transduction with miR-9 (MOI ¼ 50) for 72 h, Annexin V/PI staining of Tca8113 and SCC-9 cells showed that B26% and B34% of cells were annexin V positive, respectively. These data suggested that the inhibitory effect on the expression of miR-9 indeed promote Tca8113 and SCC-9 cell apoptosis (Figures 3d-f ).
Inhibition of tumor cell proliferation by miR-9 overexpression in vivo To investigate whether miR-9 expression caused inhibitory effect on preestablished tumor growth in nude mice, we observed and measured tumor sizes in 36-nude mice in a 35-day follow-up period. On day 42, we found a rapid increase in the Tca8113 tumors volume in the mock (2139±369 mm 3 ) and miR-control (2568 ± 732 mm 3 ) groups when compared with the miR-9 LV (423 ± 98 mm 3 ) group (Po0.01), and the same tendency was found in SCC-9 tumors. The volume of tumors in mock (2310 ± 496 mm 3 ) and miR-control (2489 ± 735 mm 3 ) groups were significantly increased when compared with the miR-9 LV (512±88 mm 3 ) group (Po0.01). However, there were no differences in tumor size and growth tendency between mock and miRcontrol groups either in Tca8113 or in SCC-9 tumors (Figures 4a-c) .
To determine whether the vectors were transduced into tumor cells, GFP expression of tumor tissues was assessed by counting 10-random fields of the frozen sections under an inverted fluorescence microscope (FL) Â 100 ( Figure 4d ). This vector independently expresses a green fluorescent protein that allows direct monitoring of the delivery efficiency of the gene-silencing construct. The delivery efficiency ofmiR-control and miR-9 LV groups was approximately 75%, and no GFP expression was observed in the mock group, as expected.
MiR-9 expression inhibited the protein expression of CXCR4 and Ki-67 in vivo To further confirm whether miR-9 expression can inhibit OSCC cells proliferation and regulate the CXCR4 expression in tumor tissues, we analyzed the protein expression of CXCR4 and miR-9 inhibits the proliferation of OSCC T Yu et al proliferation-related gene Ki-67 by immunohistochemistry, and the results showed that CXCR4 and Ki-67 protein expression was weaker in the miR-9 LV group than that in mock and miR-control groups (Figures 4e-f) . These results indicate that miR-9 overexpression can significantly regulate CXCR4 protein expression and inhibit the tumor growth in vivo.
miR-9 inhibits the proliferation of OSCC T Yu et al CXCR4 is a target gene of miR-9 Using the Target Scan (http://www.targetscan.org), we found that the protein encoded by CXCR4 was a potential target of posttranscriptional repression by miR-9 (Figures 5a and b) . We have performed a luciferase reporter assay to determine whether CXCR4 mRNA had a target site for miR-9. We used a vector encoding either the partial sequence of the 3 0 -UTR of CXCR4 mRNA, including the predicted miR-9 target site (positions 402-408), or a vector lacking the miR-9 target site. The results indicate that the luminescence intensity was significantly reduced by transfection of the wild-type 3 0 -UTR of CXCR4 while deletion of positions 402-408 blocked the decrease of luminescence in Tca8113 or SCC-9 cells (Po0.01, Figures 5c-f) .
Consequently, the downregulation of miR-9 expression in Tca8113 and SCC-9 cells was concurrent with the upregulation Figure 5 . CXCR4 is a direct target gene of miR-9. (a, b): We used a vector encoding either the partial sequence of the 3 0 -UTR of CXCR4 mRNA, including the predicted miR-9 target site (positions 402-408) or a vector lacking the miR-9 target site. (c, f ) Interaction of miR-9 with CXCR4 3 0 -UTR. After 24 h transfection with miR-9, miR-control or mocks, a reporter plasmid containing CXCR4 wild type-3 0 -UTR or deletion-3 0 -UTR and a plasmid expressing Renilla luciferase (hRluc) were co-transfected into Tca8113 and SCC-9 cells. Firefly luciferase activity was normalized to Renilla luciferase activity. Relative luciferase activity in miR-9 transfectants was compared with that in mock cultures, which was set at 1, in cells transfected with wild type-3 0 -UTR or deletion-3 0 -UTR. (g, h): CXCR4 protein levels were assessed post-transfection with miR-9 LV (MOI ¼ 50), control (100 nM), or inhibitor (100 nM) in Tca8113 and SCC-9 cells. b-Actin loading control is also shown. (i, j) Densitometric analysis of protein levels of CXCR4, relative to b-Actin, determined by western blotting and compared with Tca8113 and SCC-9 cells. Error bars indicate mean ± s.d.; n ¼ 3 experiments; **Po0.01.
, we employed a gene overexpression approach to examine the effect of miR-9 on the CXCR4 protein. The Tca8113 and SCC-9 cells were transfected with a miR-9 LV or inhibitor. CXCR4 protein expression, determined via western blot, was downregulated in miR-9 mimics-transfected cells relative to the control cells. By contrast, CXCR4 protein expression was upregulated in miR-9 inhibitor-transfected cells (Figure 5g-j) .
MiR-9 inhibits tumorigenesis by regulating expression of CXCR4 via the Wnt/b-catenin signaling pathway in OSCC cells CXCR4 is the promoter of the Wnt/b-catenin signaling pathway, so we hypothesized that miR-9 might play a role relevant to Wnt/bcatenin signaling. To test our hypothesis, we detected b-catenin protein levels by western blot in miR-9 LV-transfected cells. The expression of b-catenin protein levels was substantially reduced by B80% and 90% in miR-9-LV-expressing Tca8113 and SCC-9 cells, respectively, compared to their parental cells. Furthermore, we detected the downstream genes of the Wnt/b-catenin signaling pathway, including Bcl-2, c-myc and c-Jun. Expression of these genes was tested using western blot in mock, controland miR-9 LV-transfected cells. Results indicate that the upregulated miR-9 could repress protein levels of Bcl-2, c-myc and p-cJun, but did not affect c-Jun (Figures 6a-d) . To determine whether miR-9 functions by targeting CXCR4, we inhibited CXCR4 expression by CXCR4-LV, and tested the protein levels of b-catenin, Bcl-2, c-myc, p-c-Jun and CXCR4. We observed downregulated expression of these proteins, suggesting that CXCR4 is the target gene of miR-9 (Figures 6e-h ).
DISCUSSION
Despite considerable advances in cancer treatment, the overall survival rate of OSCC patients has not markedly improved. Therefore, it is necessary to pursue new concepts to enhance treatment results and to develop new therapeutic strategies. In recent years, emerging evidence has demonstrated an important role for miRNAs in regulating human cancers. 26 Functional studies have directly documented the potent pro-and antitumorigenic activity of specific miRNAs both in vitro and in vivo. 27 These miRNAs are involved in tumor cell processes like proliferation, apoptosis, angiogenesis, migration and metastasis. 28 Several studies have revealed that miR-9 may target multiple signaling pathways, such as the NF-kB1 and Notch signaling pathway, to promote the development and progression of malignancy. 29, 30 Aberrant miR-9 levels have been reported in many types of cancer, suggesting that miR-9 is involved in tumor formation or progression. However, by regulating various mRNA targets, miR-9 may have oncomir activity in some types of cancer cells. 31, 32 For example, miR-9 is overexpressed in human primary brain tumors, Hodgkin's lymphoma cells and some types of gastric cancer cells. 21, 33, 34 MiR-9 knockdown inhibits the proliferation of human gastric cancer cells and overexpression of CDX2, a direct target of miR-9, has a similar effect. In contrast, downregulation of miR-9 is also noted in pancreatic cancer, gastric cancer and ovarian cancer. [35] [36] [37] We have taken the position that identification of novel cancer pathways and responsible genes regulated by miR-9 is an important first step in understanding OSCC oncogenesis. Based on this view, using the algorithm Target Scan (http:// www.targetscan.org), miR-9 has seven nucleotides of the 'seed' region that are complementary to the CXCR4 3 0 -UTR. We predicted that the CXCR4 gene is a target of post-transcriptional repression by miR-9 and performed the functional verification. Our luciferase reporter assay demonstrated that miR-9 directly regulated CXCR4 in OSCC cells. CXCR4 is a highly conserved seven-span transmembrane G-protein-coupled receptor that binds the ligand CXCL12. 38 To date, CXCR4 is one of the most common chemokine receptors that has been demonstrated to be overexpressed in more over 23 human cancers.
39 CXCR4 selectively binds the CXC chemokine stromal cell-derived factor 1 (or CXCL12), which has been found to play an important role in tumorigenesis, proliferation, metastasis and angiogenesis in cancers. 24 The Wnt/b-catenin canonical Wnt-signaling pathway has been implicated in tumorigenesis at several sites, including the colon, rectum, breast and liver. 40 Its central component, namely, b-catenin, plays a critical role in this process. A number of downstream target genes of Wnt/b-catenin signaling have been reported that play critical roles in carcinogenesis by affecting cell growth, cell cycling, cell survival and invasion. Aberrant activation of Wnt signaling is a significant feature of human pancreatic adenocarcinoma, as revealed by aberrant b-catenin expression in a significant fraction (30-65%) of tumors. 41, 42 However, the relative mechanism underlying the upstream and downstream modulation function of stromal cell-derived factor-1/CXCR4 on OSCC progression is poorly understood.
In this study, we demonstrated that miR-9 was significantly downregulated in four OSCC cell lines, compared to the human normal oral keratinocytes. In addition, we analyzed the expression levels of miR-9 in 16-clinical tongue oral squamous cell carcinoma specimens and their adjacent non-cancerous specimens. The results indicate that the expression levels of miR-9 were significantly lower in 16-clinical tongue OSCC specimens than in adjacent non-cancerous specimens. Lentivirus-mediated miR-9 overexpression in vitro significantly inhibited the proliferation, colony formation and invasion of OSCC cells, while inducing their cell cycle arrest and apoptosis. After constructing the xenograft tumor models using Tca8113 and SCC-9 cells in nude mice, the tumor volume in the miR-9 LV treatment group was significantly lower than those in the mock and miR-control groups on day 42. These findings demonstrated that miR-9 can be classified as a tumor-suppressive microRNA in OSCC and might be a promising target for cancer therapeutics. To further identify the molecular mechanism of miR-9 expression on OSCC tumor progression in vivo, the CXCR4 and Ki-67 protein expression with immunohistochemistry were examined. The results indicate that the CXCR4 and Ki-67 protein expression significantly decreased in tumors treated with miR-9 LV compared with those in the mock and miR-control groups. These data indicate that lentivirusmediated miR-9 overexpression could inhibit tumor progression of OSCC cells both in vitro and in vivo. As CXCR4 expression is involved in the Wnt pathway 43, 44 and the wnt/b-catenin signaling pathway has been reported to be activated in OSCC, 45 we speculated that miR-9 might inhibit tumorigenesis by regulating Wnt/b-catenin signaling via CXCR4. To elucidate the underlying mechanism, we detected the expression levels of b-catenin and the genes downstream of the Wnt/b-catenin signaling pathway, including Bcl-2, c-myc, c-Jun and p-c-Jun. The results showed that miR-9 underexpression promoted the expression of CXCR4 proteins, which activated the effect of CXCR4 on Wnt/b-catenin signaling. The activated b-catenin was then translocated into the nucleus, where it in turn activated its downstream effectors and functionally contributed to tumorigenesis. 46 In the present study, we demonstrated for the first time that miR-9 functions as a tumor-suppressive miRNA in OSCC via targeting CXCR4 and inhibiting the Wnt/b-catenin signaling pathway.
Taken together, the results suggest that miR-9 has a crucial role in OSCC progression through its target gene, CXCR4; this disruption contributes to tumorigenesis via the Wnt/b-catenin signaling pathway. Therefore, miR-9 may be a future therapeutic target for the treatment of OSCC.
MATERIALS AND METHODS

Cell lines and reagents
Human tongue squamous cell carcinoma cell lines, including SCC-4, SCC-9, SCC-25, Tca8113, and a human normal oral keratinocyte cell line were obtained from ATCC and the State Key Laboratory of Oral Diseases at Sichuan University, respectively. The primary antibodies to human bcatenin, Bcl-2, c-myc, c-Jun, p-c-Jun, CXCR4, Ki-67 and b-actin, and the secondary antibodies and miR-9 inhibitor were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Cell proliferation and cytotoxicity assay kit were from Dojindo Laboratories (Kumamoto, Japan). Annexin V-FITC/PI Apoptosis kit was purchased from KeyGEN BioTECH (Nanjing, China).
Construction of lentiviral vector for overexpression of miR-9 and knockdown of human CXCR4 expression
To generate lentivirus-encoding miR-9 (LV-miR-9), we first amplified a 386-bp DNA fragment carrying pri-miR-9 from genomic DNA using the following PCR primers: miR-9-sense, 5 0 -CGGAGATCTTTTCTCTCTTCACCCTC-3 0 and miR-9-antisense, 5 0 -CAAGAATTCGCCCGAACCAGTGAG-3 0 . The constructs were co-transfected with pHelper 1.0 and pHelper 2.0 Packing Plasmid (GeneChem, Shanghai, China) into 293T packing cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Forty-eight hours after transfection, the supernatant was collected, centrifuged at 1000 r.p.m. for 5 min and filtered through 0.22 mm pore nitrocellulose filters. LV-GFP, a control virus, was similarly produced. OSCC cells were transfected with LV-miR-9 or LV-GFP in the presence of 4 mg/ml polybrene (Sigma-Aldrich, St Louis, MO, USA) at a multiplicity of infection of 10 and centrifuged at 1800 r.p.m. for 45 min. Thereafter, cells were cultured for 72 h and analyzed by fluorescenceactivated cell sorting (BD Biosciences, Bedford, MA, USA).
siRNA was designed, based on the CXCR4 sequence (NM_001008540): siRNA: 5 0 -GGTGGTCTATGTTGGCGTCTG-3 0 . Oligonucleotides with a sequence predicted to induce efficient RNAi of CXCR4 (containing sense and antisense sequences) were synthesized (siRNA sense: 5 0 -GATCCCGGGTGGTCTATGTTGGCGTCTGGAA GCTTGCAGACGCCAACATAGAC CACCTTTTTT-3 0 , antisense: 5 0 -CTAGAAAA AAGGTGGTCTATGTTGGCGTCTG-CAAGCTTCCAGACGCCAACATAGACCACCCGG-3 0 ; These oligonucleotides were annealed in STE buffer at 94 1C for 5 min and cooled gradually. The double-stranded products were cloned downstream to the human U6 promoter of the pRNAT/U6 vector and designated as CXCR4-shRNA. A control vector (NC-shRNA) was constructed (5 0 -GAAGCAGCACGACTTCTTC-3 0 ) with no significant homology to any mammalian gene sequence and, therefore, served as a nonsilencing control. The resulting lentiviral vector containing two human CXCR4 shRNA was named CXCR4-lentivirus (CXCR4-LV). A negative control lentiviral vector containing NC-shRNA was constructed by a similar process (NC-LV).
Cell culture and treatment
The cells were cultured at 37 1C in 5% CO 2 in DMEM containing 10% fetal bovine serum (FBS, Gibco, Rockville, USA), 2 mM glutamine, 1 mM sodium pyruvate, 10 mM HEPES, 100 U/ml penicillin G, 100 mg/ml streptomycin (Sigma, St Louis, MO, USA). Tca8113 and SCC-9 cells were infected by addition of lentivirus into the cell culture at an MOI of approximately 50.
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After culturing for another 72 h, fluorescence-activated cell sorting was done for quantitation of infection efficiency.
Real-time quantification of mature miR-9 by stem-loop RT-PCR The total RNAs from tumor tissues and cells were isolated using TRIzol reagent according to the manufacturer's instructions. Complementary DNA was synthesized from total RNA (1 mg) in 20 ml reactions, using reverse transcriptase (Epicentre, Madison, WI, USA) and the RT primer for miR-9 or RNU48 obtained from Invitrogen. The PCR mixtures were incubated at 95 1C for 5 min, and this was followed by 40 cycles of 95 1C for 10 s, 60 1C for 20 s, 72 1C for 20 s and 78 1C for 20 s. All PCR reactions were performed in triplicate using a Rotor-Gene 3000 real-time PCR system (Corbett Research, Mortlake, NSW, Australia). The expression of miR-9 were based on the 2-delta delta Ct method, using RNU48 as an internal control. All reactions were performed in triplicate, and included negative control reactions that lacked cDNA.
Cell proliferation assays
Cells transfected with miRNA plated in 96-well plates at 3 Â 10 3 cells per well. After 72 h, cell proliferation was determined with the XTT assay, using the Cell Proliferation Kit II (Roche Molecular Biochemicals, Mannheim, Germany) as previously reported. 47 Triplicate wells were measured for cell viability in each treatment group. Additionally, we used plate colony formation assay to evaluate the colony formation ability of tumor cells. The tumor cells were cultured at 1000 cells/5 ml with DMEM medium and 10% FBS in a six-well plate. After 10 days in culture, the cells were fixed with methanol for 10 min and stained with 1% crystal violet solution for 20 min to visualize colonies for counting.
Cell cycle assay A total of 1 Â 10 6 cells were taken from appropriate samples and stained with propidium iodide to stain nuclei. Flow cytometry was done using a FACS Calibur (BD Biosciences) and the fraction of cells in each phase of cell cycle was determined using cell cycle analysis platform in FlowJo software (Tree Star Inc., Ashland, OR, USA).
Apoptosis assay
Cells (1 Â 10 6 ) were collected, washed and resuspended in phosphatebuffered saline (PBS), annexin V-fluorescein isothiocyanate (FITC; 5 ml/ml; KeyGEN, Nanjing, China) and propidium iodide (PI; KeyGEN) were added and incubated for 20 min at 4 1C. Cells were analyzed by FACScan flow cytometer (Becton Dickinson) with FlowJo software (Tree Star Inc.).
Cell invasion assay
The cell invasion assay was performed with QCM 24-well Invasion Assay kit (Chemicon International, Temecula, CA, USA). This kit contains 24 inserts and each insert contains an 8-mm-pore-size polycarbonate membrane coated with a thin layer of ECMatrix. Briefly, cells were resuspended in serum-free RPMI 1640 and 3 Â 10 5 cells were added to the interior of the inserts, which had been previously rehydrated at room temperature for 30 min. Five hundred microliters of RPMI 1640 containing 10% fetal bovine serum was added to the lower chamber as chemoattractant. Cells were incubated for 48 h at 37 1C in a CO 2 incubator (5% CO 2 ). Then, the upper surface of the chamber was scraped to remove non-invasive cells. Invaded cells were fixed and stained with 0.1% crystal violet and photographed under a light microscope ( Â 200). The stained inserts were transferred to a clean well containing 500 ml of 10% acetic acid for 15 min at room temperature. The optical density of the stained cell was measured at 560 nm.
Tumor xenografts model and miR-9 recombinant lentiviral vector treatment
The construction of the tumor xenografts model was conducted at the Laboratory Animal Center of Sichuan University (Chengdu, China). The animal experiment was authorized by the West China Hospital Ethics Committees. Thirty-six nude mice (4 weeks of age) were bred in an aseptic condition and kept at a constant humidity and temperature (25-28 1C) with a 12-h light-dark cycle. After 1 week of acclimatization, 0.1 ml of Tca8113 and SCC-9 cell suspension at a concentration of 2 Â 10 6 cells/ml was subcutaneously injected into the right lateral of axilla region. Tumor xenografts were staged for 7 days and reached approximately 150 mm 3 in size. Then, the same volume (0.1 ml) of saline solution (mock), control vector (miR-control) and miR-9 LV were injected into multiple sites intratumorally in three different groups, respectively, every 7 days. The size of tumors was measured with vernier calipers, and the volume of tumor was determined using the simplified formula of a rotational ellipsoid (L Â W 2 Â 0.5). On day 42, mice were euthanized and the tumors were removed for further study.
Immunohistochemistry
Five-micrometer slices of formalin-fixed and paraffin-embedded tissues were cut onto silanized glass slides, deparaffinized in xylene, rehydrated in graded ethanol concentrations (100, 95, 70 and 50%) and finally submerged in phosphate-buffered saline (PBS). The slices were blocked endogenous pre-oxidase with 3% hydrogen peroxide solution for 15 min and placed in an autoclave with 0.01 M sodium citrate solution at 121 1C for 3 min for antigen retrieval. Tissue slices were incubated with the CXCR4, Ki-67 primary antibody overnight at 4 1C and then incubated with biotinlabeled secondary antibody at room temperature for 1 h. Negative controls were performed by replacing the primary antibody with PBS. DAB (diaminobenzidine tetrahydrochloride) was used as a chromogen. All slices were then counterstained with hematoxylin and then observed in a bright field microscope.
Plasmid construction and luciferase reporter assay
Partial wild-type sequences of CXCR4 3 0 -UTR and those with deleted miR-9 target sites (positions 402-408) were inserted between the XhoI-PmeI restriction sites in the 3 0 -UTR of the hRluc gene in psiCHECK-2 vector (Promega, San Luis Obispo, CA, USA). The synthesized DNA was cloned into the psiCHECK-2 vector. Tca8113 and SCC-9 cells were transfected with 10 ng of vector, 10 nM of miR-9 and 1 ml of Lipofectamine 2000 (Invitrogen) in 100 ml of Opti-MEM (Invitrogen). The activities of firefly and Renilla luciferases in cell lysates were determined with a dual-luciferase assay system (Promega). Normalized data were calculated as the quotient of Renilla/firefly luciferase activities.
Western blotting
The cells were lysed in lysis buffer (PBS containing 1% Triton X-100, protease inhibitor cocktail and 1 mmol/l phenylmethylsulfonyl fluoride) at 4 1C for 30 min. Equal quantities of protein were subjected to SDS-PAGE. After transfer to Immobilon-P transfer membrane, successive incubations with anti-b-catenin, bcl-2, c-myc, c-Jun, p-c-Jun, CXCR4 and b-actin antibody, and horseradish peroxidase-conjugated secondary antibody were carried out. The immunoreactive proteins were then detected using the ECL system. Bands were scanned using a densitometer (GS-700, BioRad Laboratories, Richmond, CA, USA) and quantification was performed using Quantity One 4.6.3 software (Bio-Rad Laboratories).
Statistical analysis
Data are expressed as mean±s.d., when normally distributed. The statistical significance of differences was determined by Student's twotailed t-test in 2 groups and one way analysis of varience (ANOVA) in multiple groups. Differences at probability of less than 0.05 were considered statistically significant. All data were analyzed with SPSS 15.0 software.
